Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/12/14 → 06/15/17 |
Funding
- Teva Branded Pharmaceutical Products R&D Incorporated: $140,312.00
Effect of 2.5 years of rasagiline thearpy on progression of cognitive biomarkers assessed by MRI in Parkinson's disease
- Guttuso, Thomas (PI)
- Zivadinov, Robert (CoI)
- Lichter, Michael (CoI)
Project: Research